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An editorial introduction to the series of BMJ articles about
research fraud and theMMR scare ends by noting that the affair
“raises important questions about . . . what can be done to
prevent something like this happening again.”1 At least one of
the answers to this question was identified a decade ago. Two
years after a consensus conference onmisconduct in biomedical
research held in Edinburgh,2 a proposed blueprint for the
prevention and investigation of research misconduct was
published by authors representing several medical royal colleges
and the Faculty of Pharmaceutical Medicine.3 4
One of its pivotal recommendations was the need to establish
a rapid response process through which institutions could call
on independent teams of trained external assessors, to investigate
allegations of research misconduct.4 With the exception of one
small private organisation, MedicoLegal Investigations,4 no
other capacity yet exists within the UK.5 Meanwhile there
continue to be scandalous and costly delays in investigating
allegations and suspicions of research misconduct, and in
identifying innocent as well as guilty researchers.
In 2004 the Sunday Times published an article by the journalist
Brian Deer alleging misconduct by researchers at the Royal
Free Hospital medical school in London.6 Six years earlier
Andrew Wakefield and colleagues had reported an association
between MMR vaccine and childhood autism in a paper
published in the Lancet.7 John Reid, the then health secretary,
called for an inquiry by the General Medical Council (GMC)
as a matter of urgency.6However, it was not until six years later,
after extensive further research by Mr Deer, that the GMC’s
fitness to practice committee upheld the majority of Mr Deer’s
allegations. The committee found Dr Wakefield and his senior
coauthor, John Walker-Smith, guilty of serious professional
misconduct, including, in Dr Wakefield’s case, dishonesty.
Charges were proved against a third coauthor, Simon Murch,
but he apologised to the GMC; he was deemed to have shown
insight and was therefore discharged. The role of the remaining
10 coauthors, who were not arraigned by the GMC, has not been
investigated. Nor have the failings at DrWakefield’s institution,
the Royal Free Hospital medical school, in its wholly inadequate
response to serious allegations of misconduct in 2004.
In the late 1990s, another journalist, Brian Morgan, together
with a pressure group and the then editor of the Bulletin of
Medical Ethics Richard Nicholson, alleged that researchers
associated with a controlled trial involving preterm infants in
Stoke on Trent8 were guilty of research misconduct, including
forgery of consent forms.9 A media frenzy followed.10 This led
to numerous unpublished inquiries and one requested by the
health secretary, none of which found any evidence of
misconduct, let alone forged consent forms.9 However, the
clinicians who had been targeted by the campaign had to wait
11 years before the GMC eventually judged that they had no
case to answer.9 This delay in justice had devastating effects on
the doctors and nurses and their families who had been publicly
vilified11 as well as on clinical research in the UK.9 12
Apart from the failure to identify efficiently those guilty and
those innocent of research misconduct, current inefficiency
wastes millions of pounds. Taken together, the investigations
of alleged research misconduct at the Royal Free Hospital and
in Stoke on Trent have been estimated to have cost at least £12m
(€13m; $19m).9 13 In addition, many other costs may be incurred,
as well as harm to patients, both because of failure to expose
flawed research or because of unwarranted promulgation of
doubts about reliable research.
These two examples show the consequences of the UK’s failure
to make efficient and effective arrangements for establishing
the facts in response to allegations of research misconduct. The
UK Research Integrity Office (UKRIO) may be able to resolve
uncertainties about whether misconduct has occurred in some
cases,14 and it has issued useful guidance on how to undertake
investigations. But UKRIO does not currently have the
professional forensic expertise, the mandate, or the capacity
needed to investigate allegations independently.9 15
Although institutions that employ researchers do sometimes
mount and report credible investigations into allegations of
research fraud, the default assumption should probably be that
they are not sufficiently independent. They have an obvious
conflict of interest because of the inevitable pressures on them
to protect their reputations. These pressures may trump a duty
to protect the integrity of science.16
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In addition to the need for independence, however, some
investigations require forensic expertise so that the facts can be
established before attempts are made to reach safe judgments.
Although it will sometimes be possible to establish relatively
easily that research misconduct has occurred (in confirming
plagiarism, for example), skilled forensic experience is needed
to establish the facts in other, less easily investigated allegations,
such as the two we have cited. As a member of staff at the GMC
remarked during discussion of the allegations made about
researchers in Stoke on Trent, most institutions “would not have
any idea how to set up and carry forward an inquiry into a
difficult and high profile case.”9 As noted by the Organisation
for Economic Cooperation and Development’s 2007 global
science forum, “All those responsible for procedures to
investigate research misconduct . . . should have received
training in the application of the procedures and/or be
experienced in their use.”17
Proper procedures for investigating allegations of research
misconduct, including skilled forensic capability, are needed
without further delay. Furthermore, publication of the outcome
of each investigation should be required for all research, whether
publicly or commercially funded. Because organisations that
fund research have a strong interest in its integrity, they could
support these measures by small pro rata payments. The costs
would amount to a tiny proportion of total UK research
expenditure.
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